In addition, many delegations hold that the distinction between "information" and "advertising" is not sufficiently clear and therefore fear that the proposals will not provide sufficient guarantees that the prohibition of advertising of prescription-only medicinal products to the general public will not be circumvented.
Lisaks on paljud delegatsioonid arvamusel, et vahetegemine „teavitamisel” ja „reklaamimisel” ei ole piisavalt selge ja kardavad seega, et ettepanekud ei anna piisavaid tagatisi, et üldsusele retseptiravimite reklaamimise keelamisest ei hoiduta kõrvale.